BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Cervical cancer AND TGFBR2, AAT3, 7048, ENSG00000163513, P37173, TGFbeta-RII, RIIC, TAAD2, FAA3, TGFR-2, MFS2, HNPCC6
10 results:

  • 1. ROS1 as a possible prognostic biomarker of cervical adenocarcinoma: An exploratory analysis with next-generation sequencing.
    Machida H; Matsuo K; Tanaka M; Kitatani K; Takase A; Yokoyama K; Kajiwara H; Yasaka M; Ikeda M; Yoshida H; Hirasawa T; Mikami M
    Gynecol Oncol; 2023 Apr; 171():59-66. PubMed ID: 36804622
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. In-silico analysis reveals Quinic acid as a multitargeted inhibitor against cervical cancer.
    Ahmad S; Sayeed S; Bano N; Sheikh K; Raza K
    J Biomol Struct Dyn; 2023 Nov; 41(19):9770-9786. PubMed ID: 36379678
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Establishment of multifactor predictive models for the occurrence and progression of cervical intraepithelial neoplasia.
    Chen M; Wang H; Liang Y; Hu M; Li L
    BMC Cancer; 2020 Sep; 20(1):926. PubMed ID: 32993576
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. tgfbr2 Regulates Hedgehog Pathway and cervical cancer Cell Proliferation and Migration by Mediating SMAD4.
    Yuan J; Yi K; Yang L
    J Proteome Res; 2020 Aug; 19(8):3377-3385. PubMed ID: 32628850
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification and characterization of tumorigenic circular RNAs in cervical cancer.
    Huang H; Chen YF; Du X; Zhang C
    Cell Signal; 2020 Sep; 73():109669. PubMed ID: 32423867
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Association of iRhom1 and iRhom2 expression with prognosis in patients with cervical cancer and possible signaling pathways.
    Xu Q; Chen C; Liu B; Lin Y; Zheng P; Zhou D; Xie Y; Lin Y; Guo C; Liu J; Li L
    Oncol Rep; 2020 Jan; 43(1):41-54. PubMed ID: 31661139
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MiR-17-5p promotes cervical cancer cell proliferation and metastasis by targeting transforming growth factor-β receptor 2.
    Cai N; Hu L; Xie Y; Gao JH; Zhai W; Wang L; Jin QJ; Qin CY; Qiang R
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1899-1906. PubMed ID: 29687841
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Concomitant underexpression of tgfbr2 and overexpression of hTERT are associated with poor prognosis in cervical cancer.
    Yang H; Zhang H; Zhong Y; Wang Q; Yang L; Kang H; Gao X; Yu H; Xie C; Zhou F; Zhou Y
    Sci Rep; 2017 Feb; 7():41670. PubMed ID: 28195144
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrated genomic and molecular characterization of cervical cancer.
    ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
    Nature; 2017 Mar; 543(7645):378-384. PubMed ID: 28112728
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Decreased expression of human papillomavirus E2 protein and transforming growth factor-beta1 in human cervical neoplasia as an early marker in carcinogenesis.
    Torng PL; Chan WY; Lin CT; Huang SC
    J Surg Oncol; 2003 Sep; 84(1):17-23. PubMed ID: 12949986
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.